Framework for the Provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies

East Midlands Pharmacy CollaborativecontractContracts FinderRef CF-2533200D0O000000rwimUAASME suitableclosed
View buyer

Estimated value

£2.8m

Awarded value

Suppliers

0

Lots

1

0 awarded

Published

09 Aug 2024

Deadline 11 Oct 2024

Description

This Framework agreement is for the provision of Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies initially for patients of East Midlands Pharmacy Collaborative (EMPC) Member Trusts referred to henceforth as the 'Service' to Participating Purchasing Authorities

Scope

Reference
CF-2533200D0O000000rwimUAA
Total value
£2,760,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
30 Apr 2025 to 29 Apr 2027
CPV classifications
85100000
Particular suitability
Small and medium-sized enterprises (SME)

Submission & procedure

Submission deadline
11 Oct 2024, 11:00 am